- Could You Spot the Silent Symptoms of Stress?
- Gas Stoves Could Leave Your Lungs Vulnerable to Nitrogen Dioxide
- Key Therapy Equally Effective for Women, Men With Narrowed Leg Arteries
- Doctors Describe Texas Dairy Farm Worker’s Case of Bird Flu
- Does Preschool Boost Kids’ Long-Term Academic Success? Study Finds Mixed Results
- AI Might Spot Rare Diseases in Patients Years Earlier
- An Orangutan Healed Himself With Medicinal Plant
- Quit-Smoking Meds Not Working for You? Try Upping the Dose
- Fewer Americans Are Suffering Most Dangerous Form of Heart Attack
- Even Skipping Meat for One Meal Helps Liver Disease Patients
Genetic Differences Seen in Younger Colon Cancer Patients
Colon cancer is genetically different in older and younger patients, and young adults may require different treatments, a new study suggests.
While the overall rate of colon cancer in the United States is falling, the rate is rising among younger adults. And previous research has shown that colon cancer is more aggressive in patients younger than 50 than in older people, the researchers noted.
In this study, researchers compared the genetics of five colon cancer tumors from younger patients (half of them younger than 31) and six tumors from older patients (half older than 73).
“We saw differences in two important gene signaling pathways, PPAR and IGF1R, which are involved in regulating cell development, metabolism, and growth,” Dr. Christopher Lieu, an investigator at the University of Colorado Cancer Center, said in a university news release.
Changes in these signaling pathways have been linked to several types of cancer, he and his colleagues noted.
The researchers also found that tumors from younger patients were enriched for pathways responsible for metabolizing drugs.
“Chemotherapies challenge cancer cells and younger people may metabolize these chemotherapies differently than older patients. This may explain why our traditional chemotherapy treatments may be less effective for younger patients with metastatic colorectal cancer,” study lead author Todd Pitts, a research instructor in developmental therapeutics program at the Cancer Center, said in the news release.
The study was scheduled for release this week at the annual meeting of the American Society for Clinical Oncology, in Chicago. Findings presented at meetings are usually considered preliminary until published in a peer-reviewed medical journal.
The researchers plan a larger study to confirm their findings.
“If I were to shoot for the stars, I would say that our end goal is to be able to offer better treatments for this population of young colorectal cancer patients that seems to be at higher risk from the disease,” Lieu said.
More information
The American Cancer Society has more about colon cancer.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.